Akero Therapeutics
AKRO
AKRO
94 hedge funds and large institutions have $814M invested in Akero Therapeutics in 2020 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $888M → $814M (-$73.9M)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
81% less call options, than puts
Call options by funds: $266K | Put options by funds: $1.43M
Holders
94
Holding in Top 10
4
Calls
$266K
Puts
$1.43M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$14.5M | |
| 3 | +$4.85M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.52M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4M |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$3.02M | |
| 3 | -$1.97M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.74M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.53M |